Table 1 Detailed results from individual studies
| Â | Â | Â | Â | Â | Deep infection | Superficial infection | Any catheter-related infection | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study | Patients | Cohort | Number of patients | Catheter duration (days) | Number with infection | Percent of patients affected | Per 1000 catheter days | Number with infection | Percent of patients affected | Per 1000 catheter days | Number with infection | Percent of patients affected | Per 1000 catheter days |
Aldrete 1998 | Noncancer | Retrospective | 504 | 2 to 80 days | 4 | 0.8 | no data | 5 | 1.0 | no data | 9 | 1.8 | no data |
Cherry 1985 | Cancer | Prospective | 50 | 4200 | 0 | 0.0 | 0.0 | 2 | 4.0 | 0.5 | 2 | 4.0 | 0.5 |
Crawford 1983 | Cancer (94) and benign (11) pain | Retrospective | 105 | 6825 | 1 | 1.0 | 0.1 | no data | no data | ||||
Crul 1991 | Cancer | Retrospective | 110 | 8650 | 0 | 0.0 | no data | 5 | 4.5 | no data | 5 | 4.5 | no data |
de Jong 1994 | Cancer | Retrospective | 149 | 6969 | 3 | 2.0 | 0.4 | no data | Â | Â | no data | Â | Â |
Du Pen 1990 | Cancer (339) and AIDS (11) | Retrospective | 350 | 32354 | 23 | 6.6 | 0.7 | 30 | 8.6 | 0.9 | 53 | 15.1 | 1.6 |
Erdeine 1991 | Cancer | Prospective | 225 | 10642 | 0 | 0.0 | 0.0 | 9 | 4.0 | 0.8 | 9 | 4.0 | 0.8 |
Holt 1995 | Mixed | Prospective | 1000 | 11901 | 11 | 1.1 | 0.9 | 53 | 3.6 | 3.0 | 59 | 5.9 | 5.0 |
Maier 1994 | Perioperative | Retrospective | 1621 | 12540 | 0 | 0.0 | 0.0 | 46 | 2.8 | 3.7 | 46 | 2.8 | 3.7 |
Plummer 1991 | Cancer | Retrospective | 284 | 27264 | 1 | 0.4 | 0.0 | 22 | 7.7 | 0.8 | 23 | 8.1 | 0.8 |
Smitt 1998 | Cancer | Retrospective | 91 | 4326 | 12 | 13.2 | 2.8 | 39 | 42.9 | 9.0 | 51 | 56.0 | 11.8 |
Zenz 1985 | Cancer | Prospective | 139 | 9716 | 2 | 1.4 | 0.2 | no data | Â | Â | no data | Â | Â |
Patients in studies reporting the outcome | 4628 | Â | Â | 4235 | Â | Â | 4235 | Â | Â | ||||
Overall result | 4628 | 135387 | 57 | 1.23 | 0.42 | 211 | 4.58 | 1.78 | 257 | 6.07 | 2.35 | ||